SINOVAC BIOTECH LTD (SVA) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2009: $20.06M2010: $16.72M2011: $21.13M2012: $19.10M2013: $20.50M2014: $15.48M2015: $18.41M2016: $22.39M2017: $20.24M2018: $24.72M2019: $32.47M2020: $67.18M2021: $988.92M2022: $658.19M2023: $146.85M2024: $140.69M2025: $124.03M$124.03M
2009Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$124.03M-11.8%
2024$140.69M-4.2%
2023$146.85M-77.7%
2022$658.19M-33.4%
2021$988.92M+1372.0%
2020$67.18M+106.9%
2019$32.47M+31.3%
2018$24.72M+22.1%
2017$20.24M-9.6%
2016$22.39M+21.6%
2015$18.41M+18.9%
2014$15.48M-24.5%
2013$20.50M+7.4%
2012$19.10M-9.6%
2011$21.13M+26.4%
2010$16.72M-16.7%
2009$20.06M